These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27513348)

  • 41. Impact of carotid atherosclerosis loci on cardiovascular events.
    Hemerich D; van der Laan SW; Tragante V; den Ruijter HM; de Borst GJ; Pasterkamp G; de Bakker PI; Asselbergs FW
    Atherosclerosis; 2015 Dec; 243(2):466-8. PubMed ID: 26520901
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.
    Ahmad A; Sundquist K; Zöller B; Dahlbäck B; Svensson PJ; Sundquist J; Memon AA
    Thromb Haemost; 2016 Aug; 116(3):432-41. PubMed ID: 27277397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeted Sequencing Study to Uncover Shared Genetic Susceptibility Between Peripheral Artery Disease and Coronary Heart Disease-Brief Report.
    Safarova MS; Fan X; Austin EE; van Zuydam N; Hopewell J; Schaid DJ; Kullo IJ
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1227-1233. PubMed ID: 31070467
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism.
    Sticchi E; Magi A; Kamstrup PR; Marcucci R; Prisco D; Martinelli I; Mannucci PM; Abbate R; Giusti B
    PLoS One; 2016; 11(2):e0149427. PubMed ID: 26900838
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of mitochondrial DNA variants associated with genome-wide blood cell gene expression: a population-based mtDNA sequencing study.
    Laaksonen J; Seppälä I; Raitoharju E; Mononen N; Lyytikäinen LP; Waldenberger M; Illig T; Lepistö M; Almusa H; Ellonen P; Hutri-Kähönen N; Juonala M; Kähönen M; Raitakari O; Salonen JT; Lehtimäki T
    Hum Mol Genet; 2019 Apr; 28(8):1381-1391. PubMed ID: 30629177
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of the CYP4V2 polymorphism rs13146272 with venous thromboembolism in a Chinese population.
    Yue Y; Sun Q; Man C; Fu Y
    Clin Exp Med; 2019 Feb; 19(1):159-166. PubMed ID: 30276487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Correlation analysis of thrombin-activatable fibrinolysis inhibitor single nucleotide polymorphism with venous thromboembolism].
    Li C; Hou LH; Liu XE; Huang C; Wei XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):949-53. PubMed ID: 22931662
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor.
    Klarin D; Emdin CA; Natarajan P; Conrad MF; ; Kathiresan S
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28373160
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of Genetic Interaction with Risk Factors Using a Time-To-Event Model.
    de Andrade M; Armasu SM; McCauley BM; Petterson TM; Heit JA
    Int J Environ Res Public Health; 2017 Oct; 14(10):. PubMed ID: 29036934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.
    Otrock ZK; Taher AT; Shamseddeen WA; Zaatari G; Bazarbachi A; Mahfouz RA
    Ann Hematol; 2008 Dec; 87(12):1013-6. PubMed ID: 18654780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Family history of myocardial infarction and cause-specific risk of myocardial infarction and venous thromboembolism: the Tromsø Study.
    Lind C; Enga KF; Mathiesen EB; Njølstad I; Brækkan SK; Hansen JB
    Circ Cardiovasc Genet; 2014 Oct; 7(5):684-91. PubMed ID: 25087051
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional haplotypes of the hTERT gene, leukocyte telomere length shortening, and the risk of peripheral arterial disease.
    Zhang W; Chen Y; Yang X; Fan J; Mi X; Wang J; Zhang C; Hu FB; Hui R
    PLoS One; 2012; 7(10):e47029. PubMed ID: 23082138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rare genetic variants in SMAP1, B3GAT2, and RIMS1 contribute to pediatric venous thromboembolism.
    Rühle F; Witten A; Barysenka A; Huge A; Arning A; Heller C; Krümpel A; Mesters R; Franke A; Lieb W; Riemenschneider M; Hiersche M; Limperger V; Nowak-Göttl U; Stoll M
    Blood; 2017 Feb; 129(6):783-790. PubMed ID: 28011674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Family history of venous thromboembolism as a risk factor and genetic research tool.
    Zöller B; Li X; Ohlsson H; Ji J; Sundquist J; Sundquist K
    Thromb Haemost; 2015 Nov; 114(5):890-900. PubMed ID: 26305449
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of fibrinogen plasma levels, the -455G>A fibrinogen and the factor XIII A subunit (FXIII-A) Val34Leu polymorphism in cancer-associated venous thrombosis.
    Tiedje V; Dunkler D; Ay C; Horvath B; Quehenberger P; Pabinger M; Zielinski C; Pabinger I; Mannhalter C
    Thromb Haemost; 2011 Nov; 106(5):908-13. PubMed ID: 21901234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multilocus analysis in candidate genes ACE, AGT, and AGTR1 and predisposition to peripheral arterial disease: role of ACE D/-240T haplotype.
    Fatini C; Sticchi E; Sofi F; Said AA; Pratesi G; Pulli R; Pratesi C; Abbate R
    J Vasc Surg; 2009 Dec; 50(6):1399-404. PubMed ID: 19782519
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
    Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
    Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic association study of common mitochondrial variants on body fat mass.
    Yang TL; Guo Y; Shen H; Lei SF; Liu YJ; Li J; Liu YZ; Yu N; Chen J; Xu T; Cheng Y; Tian Q; Yu P; Papasian CJ; Deng HW
    PLoS One; 2011; 6(6):e21595. PubMed ID: 21747914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.
    Germain M; Chasman DI; de Haan H; Tang W; Lindström S; Weng LC; de Andrade M; de Visser MC; Wiggins KL; Suchon P; Saut N; Smadja DM; Le Gal G; van Hylckama Vlieg A; Di Narzo A; Hao K; Nelson CP; Rocanin-Arjo A; Folkersen L; Monajemi R; Rose LM; Brody JA; Slagboom E; Aïssi D; Gagnon F; Deleuze JF; Deloukas P; Tzourio C; Dartigues JF; Berr C; Taylor KD; Civelek M; Eriksson P; ; Psaty BM; Houwing-Duitermaat J; Goodall AH; Cambien F; Kraft P; Amouyel P; Samani NJ; Basu S; Ridker PM; Rosendaal FR; Kabrhel C; Folsom AR; Heit J; Reitsma PH; Trégouët DA; Smith NL; Morange PE
    Am J Hum Genet; 2015 Apr; 96(4):532-42. PubMed ID: 25772935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach.
    Trégouët DA; Heath S; Saut N; Biron-Andreani C; Schved JF; Pernod G; Galan P; Drouet L; Zelenika D; Juhan-Vague I; Alessi MC; Tiret L; Lathrop M; Emmerich J; Morange PE
    Blood; 2009 May; 113(21):5298-303. PubMed ID: 19278955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.